» Download Public Reports
About 200 reports
- Country report
- April 2013
- 21 pages
... Industrial health sectors chemical and biotech industries medicines active principles vaccines hemoderivatives biologics diagnostic reagents mechanic, electronic and material industries hospitals out ...
February 2013
... Little attention has been paid to the industry that hlf operates in: the dietary supplements industry. The dietary supplements industry is a fast- growing, multi-billion niche market ...
January 2013
... Results of torrent pharmaceuticals. On behalf of all the participants and edelweiss, we welcome torrent pharma team. Today, we have mr. Ashok modi, executive director finance, mr. R. Srinivasan ...
January 2013
... Brazil pathology 2013 report excerpts Contact michael farmer at or 415-994-8852 mcevoy & farmer diagnostic industry specialists since 1986 ...
January 2013
... Development and production of influenza vaccines instituto butantan prof. Isaias raw january 2013 butantan: goals As a public institute, the goal of butantan is to produce efficacious ...
February 2013
... Labeling, public campaigns, etc) Role of the national pharmaceutical industry Differences between the policies implemented in the public and the private sector 15/02/2013 results: brazil retail ...
February 2013
... Obesity) and related complications (diabetic nephropathy/chronic renal failure, neuropathy and neuropathic pain, retinopathy, cardiovascular disease). We also included the costs of the nutritional ...
» Purchase Premium Reports
(From $ 144 - $ 4 450)
About 200 reports
- $ 4 450
- Industry report
- February 2013
- by Global Data
MediPoint: Predictive Breast Cancer Gene Testing - South America Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. ...
May 2013
$ 3 995
EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022 Summary Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an ...
February 2013
$ 2 000
This report provides information on the therapeutic development for Edema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
March 2013
$ 1 088
Includes 3 FREE quarterly updates BMI View: Brazil remains the most attractive emerging pharmaceutical industry in the Americas due to its large population, strong consumer demand, increasing urbanisation ...
March 2013
$ 300
Summary Zambon Company S.p.A. (Zambon), the holding company of the Zambon Group, is a major multinational pharmaceutical and chemical company. It develops, manufactures and markets specialized pharmaceuticals ...
March 2013
$ 300
Summary Drogasil S.A. (Drogasil) is a drug and cosmetics retailing company, based in Brazil. The company operates through retail sale of pharmaceutical and non-pharmaceutical products sectors. It has 280-plus ...
March 2013
$ 250
Summary (RECEPTA Biopharma) RECEPTA Biopharma is a biotechnology company dedicated to the research and development of monoclonal antibodies to be used in the treatment of cancer. The company's principal ...